Home > Press > eBioscience Announces an Expansion of the eFluor(TM) Brand with the Commercial Launch of eFluor(TM) Organic Dyes
Abstract:
eBioscience Corporation, a leading global provider of innovative, high-quality cell analysis reagents, announced today the expansion of its eFluor(TM) brand with the commercial launch of the eFluor(TM) Organic Dye product line.
"We are very pleased to announce the addition of several novel organic dyes to our eFluor(TM) brand," said Todd R. Nelson Ph.D., CEO of eBioscience. "The development and commercialization of innovative, high-quality, multicolor cellular analysis research reagents remains a cornerstone of eBioscience's business," Nelson continued. "The addition of the organic dyes to our eFluor(TM) brand product line serves to both diversify our customer base and extend our reach into a rapidly growing segment of the market focused on multicolor applications."
"We are particularly excited about our ability to offer an increasing number of products, such as our eFluor(TM) 450 Organic Dye, as a replacement for Pacific Blue(R), providing our customers greater flexibility when choosing reagents for use in multicolor flow cytometry experiments," commented Tony Ward, VP Commercial Operations for eBioscience. "In addition, we are also launching a series of new APC eFluor(TM) 780 tandem conjugates that, because they have greater fluorescence intensity than competitor products, provide significant benefit to researchers designing multicolor cellular analysis experiments," Ward continued. Mike Boyer, Ph.D., eBioscience's Director of Marketing commented, "Taken together our rapidly expanding portfolio of eFluor(TM) Organic Dyes and nanocrystal reagents, when combined with our leading edge portfolio of biological content, facilitates our ability to keep eBioscience's customers at the forefront of scientific discovery."
With the launch of over 40 eFluor(TM) Organic Dye products, eBioscience Corporation is well positioned to offer to its customers an increasingly broad array of novel products that employ proprietary technologies optimized for use with standard reagents. Importantly, eFluor(TM) Organic Dyes have been designed and optimized for use with a variety of existing organic fluorochromes and nanocrystal technologies, including eBioscience's own eFluor(TM) Nanocrystals product line, and as such, provide optimal flexibility to researchers when designing multicolor experiments in the areas of flow cytometry, in vivo imaging and microscopy.
####
About eBioscience Corporation
eBioscience provides innovative high quality reagents to academic and government researchers and pharmaceutical and biotech companies worldwide that empower the process of scientific discovery in the areas of cellular immunity and oncology.
The company's extensive portfolio of more than 8,000 leading edge cell analysis reagents and technologies, focused on flow cytometry and immunodetection, position our customers to be at the forefront of science. eBioscience is aligned with and responsive to the ever changing needs of its customers, making the company a preferred partner for scientific discovery.
Founded in 1999, eBioscience is headquartered in San Diego, California and conducts business in more than 70 countries around the world.
For more information, please click here
Contacts:
eBioscience, Inc.
10255 Science Center Drive
San Diego, CA 92121
USA
Telephone Technical Support:
888.810.6168
Customer Service:
888.999.1371 or 858.642.2058
Fax 858.642.2046 (Fax)
Technical Support:
Customer Service:
Copyright © PR Newswire Association LLC.
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Imaging
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||